407 related articles for article (PubMed ID: 16906016)
1. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.
Rizzo R; Rubini M; Govoni M; Padovan M; Melchiorri L; Stignani M; Carturan S; Ferretti S; Trotta F; Baricordi OR
Pharmacogenet Genomics; 2006 Sep; 16(9):615-23. PubMed ID: 16906016
[TBL] [Abstract][Full Text] [Related]
2. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
3. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma.
Chen XY; Yan WH; Lin A; Xu HH; Zhang JG; Wang XX
Tissue Antigens; 2008 Oct; 72(4):335-41. PubMed ID: 18700878
[TBL] [Abstract][Full Text] [Related]
4. Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis.
Veit TD; Vianna P; Scheibel I; Brenol CV; Brenol JC; Xavier RM; Delgado-Cañedo A; Gutierrez JE; Brandalize AP; Schuler-Faccini L; Chies JA
Tissue Antigens; 2008 May; 71(5):440-6. PubMed ID: 18331529
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis.
Stamp LK; O'Donnell JL; Chapman PT; Barclay ML; Kennedy MA; Frampton CM; Roberts RL
Ann Rheum Dis; 2009 Jan; 68(1):154-5. PubMed ID: 19088262
[No Abstract] [Full Text] [Related]
6. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma.
Zheng XQ; Li CC; Xu DP; Lin A; Bao WG; Yang GS; Yan WH
Hum Immunol; 2010 Oct; 71(10):982-7. PubMed ID: 20600443
[TBL] [Abstract][Full Text] [Related]
9. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
Seitz M; Zwicker M; Wider B
J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
[TBL] [Abstract][Full Text] [Related]
10. The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children.
Zheng XQ; Zhu F; Shi WW; Lin A; Yan WH
Tissue Antigens; 2009 Oct; 74(4):317-21. PubMed ID: 19624485
[TBL] [Abstract][Full Text] [Related]
11. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
[TBL] [Abstract][Full Text] [Related]
12. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
[TBL] [Abstract][Full Text] [Related]
13. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
Wessels JA; Kooloos WM; De Jonge R; De Vries-Bouwstra JK; Allaart CF; Linssen A; Collee G; De Sonnaville P; Lindemans J; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Sep; 54(9):2830-9. PubMed ID: 16947783
[TBL] [Abstract][Full Text] [Related]
14. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome.
Crispim JC; Mendes-Junior CT; Wastowski IJ; Costa R; Castelli EC; Saber LT; Donadi EA
Tissue Antigens; 2008 Jan; 71(1):35-41. PubMed ID: 17971051
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression.
Hviid TV; Rizzo R; Melchiorri L; Stignani M; Baricordi OR
Hum Immunol; 2006; 67(1-2):53-62. PubMed ID: 16698426
[TBL] [Abstract][Full Text] [Related]
16. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.
Twito T; Joseph J; Mociornita A; Rao V; Ross H; Delgado DH
J Heart Lung Transplant; 2011 Jul; 30(7):778-82. PubMed ID: 21482149
[TBL] [Abstract][Full Text] [Related]
17. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
[TBL] [Abstract][Full Text] [Related]
18. Soluble HLA-G in rheumatoid arthritis.
Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
[TBL] [Abstract][Full Text] [Related]
19. In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment.
Baricordi OR; Govoni M; Rizzo R; Trotta F
Ann Rheum Dis; 2007 Aug; 66(8):1125-6. PubMed ID: 17626975
[No Abstract] [Full Text] [Related]
20. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
